Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $26
Alto Neuroscience, Inc.
Alto Neuroscience, Inc. ANRO | 0.00 |
Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:
ANRO) with a Neutral and raises the price target from $24 to $26.